Jonas Ghouse1,2, Christian T Have3, Morten W Skov1,2, Laura Andreasen1,2, Gustav Ahlberg1,2, Jonas B Nielsen1,2,4, Tea Skaaby5, Søren-Peter Olesen1, Niels Grarup3, Allan Linneberg5,6,7, Oluf Pedersen3, Henrik Vestergaard3, Stig Haunsø1,2,7, Jesper H Svendsen1,2,7, Torben Hansen3, Jørgen K Kanters8, Morten S Olesen1,2. 1. The Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark. 2. Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, Denmark. 3. The Novo Nordisk Foundation Centre for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. 4. Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA. 5. Research Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark. 6. Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark. 7. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 8. Laboratory of Experimental Cardiology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Abstract
PURPOSE: We investigated whether Brugada syndrome (BrS)-associated variants identified in the general population have an effect on J-point elevation as well as whether carriers of BrS variants were more prone to experience syncope and malignant ventricular arrhythmia and had increased mortality compared with noncarriers. METHODS: All BrS-associated variants were identified using the Human Gene Mutation Database (HGMD). Individuals were randomly selected from a general population study using whole-exome sequencing data (n = 870) and genotype array data (n = 6,161) and screened for BrS-associated variants. Electrocardiograms (ECG) were analyzed electronically, and data on syncope, ventricular arrhythmias, and mortality were obtained from administrative health-care registries. RESULTS: In HGMD, 382 BrS-associated genetic variants were identified. Of these, 28 variants were identified in the study cohort. None of the carriers presented with type 1 BrS ECG pattern. Mean J-point elevation in V1 and V2 were within normal guideline limits for carriers and noncarriers. There was no difference in syncope susceptibility (carriers 8/624; noncarriers 98/5,562; P = 0.51), ventricular arrhythmia (carriers 4/620; noncarriers 9/5,524; P = 0.24), or overall mortality (hazard ratio 0.93, 95% CI 0.63-1.4). CONCLUSIONS: Our data indicate that a significant number of BrS-associated variants are not the monogenic cause of BrS.Genet Med advance online publication 06 October 2016.
PURPOSE: We investigated whether Brugada syndrome (BrS)-associated variants identified in the general population have an effect on J-point elevation as well as whether carriers of BrS variants were more prone to experience syncope and malignant ventricular arrhythmia and had increased mortality compared with noncarriers. METHODS: All BrS-associated variants were identified using the Human Gene Mutation Database (HGMD). Individuals were randomly selected from a general population study using whole-exome sequencing data (n = 870) and genotype array data (n = 6,161) and screened for BrS-associated variants. Electrocardiograms (ECG) were analyzed electronically, and data on syncope, ventricular arrhythmias, and mortality were obtained from administrative health-care registries. RESULTS: In HGMD, 382 BrS-associated genetic variants were identified. Of these, 28 variants were identified in the study cohort. None of the carriers presented with type 1 BrS ECG pattern. Mean J-point elevation in V1 and V2 were within normal guideline limits for carriers and noncarriers. There was no difference in syncope susceptibility (carriers 8/624; noncarriers 98/5,562; P = 0.51), ventricular arrhythmia (carriers 4/620; noncarriers 9/5,524; P = 0.24), or overall mortality (hazard ratio 0.93, 95% CI 0.63-1.4). CONCLUSIONS: Our data indicate that a significant number of BrS-associated variants are not the monogenic cause of BrS.Genet Med advance online publication 06 October 2016.
Authors: Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia Journal: Arq Bras Cardiol Date: 2019-03 Impact factor: 2.000
Authors: Christian Paludan-Müller; Jonas Ghouse; Oliver B Vad; Cecilie B Herfelt; Pia Lundegaard; Gustav Ahlberg; Nicole Schmitt; Jesper H Svendsen; Stig Haunsø; Henning Bundgaard; Torben Hansen; Jørgen K Kanters; Morten S Olesen Journal: Eur J Hum Genet Date: 2019-05-01 Impact factor: 4.246
Authors: Yuya Kobayashi; Shan Yang; Keith Nykamp; John Garcia; Stephen E Lincoln; Scott E Topper Journal: Genome Med Date: 2017-02-06 Impact factor: 11.117
Authors: Christopher M Haggerty; Cynthia A James; Hugh Calkins; Crystal Tichnell; Joseph B Leader; Dustin N Hartzel; Christopher D Nevius; Sarah A Pendergrass; Thomas N Person; Marci Schwartz; Marylyn D Ritchie; David J Carey; David H Ledbetter; Marc S Williams; Frederick E Dewey; Alexander Lopez; John Penn; John D Overton; Jeffrey G Reid; Matthew Lebo; Heather Mason-Suares; Christina Austin-Tse; Heidi L Rehm; Brian P Delisle; Daniel J Makowski; Vishal C Mehra; Michael F Murray; Brandon K Fornwalt Journal: Genet Med Date: 2017-05-04 Impact factor: 8.822
Authors: Oliver Bundgaard Vad; Yannan Yan; Federico Denti; Gustav Ahlberg; Lena Refsgaard; Sofia Hammami Bomholtz; Joana Larupa Santos; Simon Rasmussen; Stig Haunsø; Jesper Hastrup Svendsen; Ingrid Elizabeth Christophersen; Nicole Schmitt; Morten Salling Olesen; Bo Hjorth Bentzen Journal: Front Genet Date: 2022-01-28 Impact factor: 4.599
Authors: Laura Andreasen; Jonas Ghouse; Morten W Skov; Christian T Have; Gustav Ahlberg; Peter V Rasmussen; Allan Linneberg; Oluf Pedersen; Pyotr G Platonov; Stig Haunsø; Jesper H Svendsen; Torben Hansen; Jørgen K Kanters; Morten S Olesen Journal: Front Physiol Date: 2018-07-10 Impact factor: 4.566